Natera Q3: Strong Revenue Growth, Narrowed Loss and New CEO LeadStrong Q3 for Natera: CEO change, 34% revenue growth, and a 32% loss reduction signal new momentum in genetic testing.NATERA INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 08/11/2026, 22:00 3 minutes to read